Mulroy Michael H. 4
4 · Lineage Cell Therapeutics, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Mulroy Michael H.
Director
Transactions
- Exercise/Conversion
Common Shares, no par value
2021-06-18$2.20/sh+24,720$54,384→ 251,555 total - Exercise/Conversion
Stock Option (right to buy)
2021-06-18−24,720→ 0 totalExercise: $2.20Exp: 2021-06-30→ Common Shares (24,720 underlying)
Footnotes (1)
- [F1]This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.